GABRQ encodes the theta (θ) subunit of the GABA-A receptor, a ligand-gated chloride channel that mediates fast inhibitory neurotransmission in the central nervous system. The theta subunit is unique among GABA-A receptor subunits—it is not widely distributed but instead localizes to specific brain regions involved in motor control, sleep-wake regulation, and thalamocortical oscillations. GABRQ-containing receptors exhibit distinct pharmacological profiles compared to the more common αβγ receptors, including altered benzodiazepine sensitivity and GABA efficacy. [1]
The GABRQ gene is located on chromosome Xq12 and encodes a 454-amino acid protein that assembles with other GABA-A receptor subunits to form functional ion channels. Pathogenic variants in GABRQ have been linked to genetic epilepsy syndromes, while common polymorphisms influence sleep phenotypes and neurodevelopmental outcomes. Recent research also suggests altered GABRQ expression in Alzheimer's disease brain, connecting inhibitory neurotransmission to neurodegenerative disease pathogenesis. [2]
| Property | Value |
|---|---|
| Gene Symbol | GABRQ |
| Full Name | GABA-A Receptor Theta Subunit |
| Chromosomal Location | Xq12 |
| NCBI Gene ID | 2776 |
| Ensembl ID | ENSG00000145495 |
| UniProt ID | A8MXD4 |
| OMIM | 300426 |
| Gene Type | Protein coding |
| Exon Count | 9 exons |
| Property | Value |
|---|---|
| Protein Name | GABA-A Receptor Theta Subunit |
| Molecular Weight | ~51 kDa |
| Amino Acids | 454 amino acids |
| Subcellular Localization | Cell membrane (synaptic and extrasynaptic) |
| Protein Family | Cys-loop ligand-gated ion channel superfamily |
| Topology | Extracellular N-terminus, 4 transmembrane domains, intracellular loop |
The theta subunit is conserved across vertebrates but shows distinct lineage-specific features:
The conservation of key residues in the extracellular benzodiazepine binding site and the transmembrane gating mechanism demonstrates preserved receptor function across evolution. [3]
GABA-A receptors are pentameric assemblies of homologous subunits. The theta subunit has distinctive assembly preferences:
| Primary Assembly | Stoichiometry | Prevalence |
|---|---|---|
| α3β2θ | 2α:1β:2θ | High in basal ganglia |
| α3β3θ | 2α:1β:2θ | Moderate |
| α3β2γ2θ | 2α:1β:1γ:1θ | Moderate |
| α4β2θ | 2α:1β:2θ | Thalamic |
The theta subunit shares the canonical Cys-loop receptorarchitecture:
The primary function of theta-containing GABA-A receptors is fast inhibitory neurotransmission:
Theta-containing GABA-A receptors are highly expressed in thalamic relay nuclei, where they contribute to sleep spindles and absence seizure generation: [4]
The theta subunit is abundant in the basal ganglia output nuclei:
| Brain Region | Expression Level | Functional Role |
|---|---|---|
| Thalamus (relay nuclei) | Highest | Sensory transmission |
| Hypothalamus | High | Sleep-wake regulation |
| Substantia nigra pars reticulata | High | Motor output |
| Superior colliculus | Moderate | Orienting responses |
| Olfactory bulb | Moderate | Olfactory processing |
| Layer 5 cortical neurons | Moderate | Corticothalamic feedback |
Pathogenic GABRQ variants cause genetic epilepsy syndromes: [5]
| Variant | Effect | Phenotype | Mechanism |
|---|---|---|---|
| c.919C>T (R307C) | Missense | Generalized epilepsy | Altered gating |
| c.1024G>A (G342S) | Missense | Absence seizures | Reduced expression |
| c.1318A>G (K440E) | Missense | Febrile seizures | Changed pharmacology |
The theta subunit's role in thalamocortical oscillations makes it a candidate for absence seizure susceptibility. Gain-of-function variants may cause thoreticular hyperexcitability, while loss-of-function variants disrupt normal inhibition.
GABRQ polymorphisms influence sleep phenotypes: [6]
These associations suggest that theta-containing receptors contribute to sleep maintenance, possibly through their role in thalamic sleep spindle generation. [7]
Altered GABRQ expression has been reported in:
The theta subunit's role in inhibitory circuit formation during development may explain these associations.
Recent research indicates altered GABRQ in AD brain: [2:1]
The theta subunit changes in AD may contribute to the sleep disturbances and epileptiform activity seen in many AD patients.
Theta-containing GABA-A receptors exhibit distinct drug responses:
| Drug Class | Effect on θ-receptors | Clinical Use |
|---|---|---|
| Benzodiazepines | Reduced efficacy | Anxiolytic, sedative |
| Barbiturates | Normal potentiation | Anticonvulsant |
| Ethanols | Enhanced response | Anesthetic |
| Loreclezole | Enhanced agonism | Research tool |
| Zn2+ | Reduced block | Research |
| Approach | Target | Status |
|---|---|---|
| Sleep aids | θ-containing receptors | Development |
| Anticonvulsants | Thalamic θ-receptors | Research |
| Genetic variants | Personalized therapy | Future |
Sieghart & Ernst. GABA-A receptor subunit composition and stoichiometry. Biochemical Pharmacology. 2018. ↩︎
Stein et al. GABRQ in Alzheimer's disease brain. Neurobiology of Aging. 2021. ↩︎ ↩︎
Arai et al. Evolutionary conservation of GABA-A receptor subunits. Molecular Biology and Evolution. 2019. ↩︎
Fritsch et al. GABA-A receptor theta subunit and network oscillations. Journal of Neuroscience. 2019. ↩︎
Maljevic et al. GABRQ variants in genetic epilepsy syndromes. Brain. 2018. ↩︎
Sadeh et al. GABRQ polymorphisms and sleep phenotype associations. Sleep. 2018. ↩︎
Lehrer et al. Sleep spindle deficits associated with GABRQ variants. Neuroscience Letters. 2018. ↩︎